Publications

INTRODUCTION: Mesenchymal stem cells ( MSCs) regulatecell processes by secreting growth factors, cytokines, chemokines,hormones and extracellular vesicles, known as secretome. This se-cretome has successfully exhibited therapeutic properties.1 Althoughsecretome can be directly administered in the target site, its fastclearance is still challenging. Therefore, new efforts have been madeto develop delivery platforms,1 that sustain secretome release andincrease its retention time.The aim of this work is to encapsulate secretome into nano-particles (NPs) for achieving a sustained release and to evaluate theirpotential in wound healing.EXPERIMENTAL METHODS: Secretome was obtained byculturing human umbilical cord MSCs under hypoxic conditions.Protein content was determined using a protein array. Secretome wasencapsulated in poly(lactic-co-glycolic) (PLGA) NPs by doubleemulsification. NPs size and zeta potential were measured using aZetasizer. The loading content and release was evaluated using amicroBCA. The secretome integrity was also assessed. NPs cellularcytocompatibility was studied using human dermal fibroblasts andkeratinocytes.RESULTS: The most expressed bioactive molecules detected inthe secretome were TIMP-2, TIMP-1, IL-6, IL-8, RANTES. NPsencapsulate between 7.2-13.5mg/mg NPs, having sizes of 300-400 nm and zeta potentials below -20 mV. NPs were biocompatibleand sustained the release for 7 days.DISCUSSION AND CONCLUSIONS: The secretome composi-tion evidenced its potential in wound healing. Secretome was suc-cessfully encapsulated in the NPs, showing a sustained release. Ourresults indicate that these nanoplatforms are promising woundhealing agents.

JTD Keywords: Msc, Nanoparticle, Secretome